An interventional study of Ultrasound-guided Pericapsular Nerve Group (PENG) Block and Ultrasound-guided Low-Volume Interscalene Brachial Plexus Block in Postoperative Pain, Shoulder Surgery and Diphragmatic Sparing, sponsored by Zagazig University. Completed at 1 site in Egypt. Open to participants aged 21 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Zagazig University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Pain, Postoperative by Zagazig University — 7 open to participants now, 8 under way, 1 of them phase 3. Pain, Postoperative · Zagazig University.
Among the 18 studies in Pain, Postoperative by Zagazig University, this one is the 8th largest by enrollment, is one of 4 that started in 2025, is one of 12 with no phase, and was the 18th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,240 are open to participants now.
Browse Pain, Postoperative studies →7 of the 18 studies in Pain, Postoperative by Zagazig University are open now, in 1 country. Recruiting first, the newest first:
Zagazig University · Sites in Egypt
Ages 21–65
Zagazig University · Sites in Egypt
Ages 21–60 · Women only
Zagazig University · Sites in Egypt
Ages 21–60 · Healthy volunteers
Zagazig University · Sites in Egypt
Ages 21–60 · Healthy volunteers
Zagazig University · Sites in Egypt
Ages 21–60 · Healthy volunteers
By country, each count listing its studies:
Of the 675 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 328 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 21 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 72 is close to the median of 75 across 4,854 interventional studies indexed under Pain, Postoperative.
Median enrollment 65 across the 18 interventional studies. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Zagazig University is the lead sponsor of 462 studies on the registry; 78 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
1 of the studies in Pain, Postoperative by Zagazig University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07883616Zagazig UniversityModified Thoracolumbar Interfascial Plane Block vs Retrolaminar Block for Pain in Lumbar Spine Surgeries | 2026-12-01 |
Add it to your calendar (.ics) → With an account.
Among the 18 studies in Pain, Postoperative by Zagazig University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized, double-blind clinical trial compared the ultrasound-guided pericapsular nerve group (PENG) block (20 mL of 0.25% bupivacaine) with low-volume interscalene brachial plexus block (ISB) (5 mL of 0.25% bupivacaine) in 72 adult patients undergoing elective unilateral shoulder surgery. The study evaluated diaphragmatic excursion via M-mode ultrasound as a measure of phrenic nerve preservation, alongside postoperative analgesic efficacy and safety.
Inclusion Criteria:
Inclusion Criteria:
Exclusion Criteria:
Patient refusal.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
• 36 patients received an ultrasound-guided pericapsular nerve group (PENG) block using 20 mL of 0.25% bupivacaine following the induction of general anesthesia.
Procedure: Ultrasound-guided Pericapsular Nerve Group (PENG) Block
• 36 patients received an ultrasound-guided low-volume interscalene brachial plexus block (ISB) using 5 mL of 0.25% bupivacaine following the induction of general anesthesia.
Procedure: Ultrasound-guided Low-Volume Interscalene Brachial Plexus Block
With the patient supine, the arm was abducted and externally rotated at 45°, and the skin was disinfected with Betadine. Using a high-frequency linear ultrasound probe, the humeral head, subscapularis tendon, and deltoid muscle were identified. A 22-gauge echogenic needle was advanced in-plane in a cranio-caudal direction between the deltoid and subscapularis muscles. After negative aspiration, 20 mL of 0.25% bupivacaine was injected
With their head toward the opposite side, the patient was placed in a supine position. Betadine was used to sterilise the neck's skin. The C7 root emerged from the C7 vertebra with no anterior tubercle when the lateral surface of the neck was exposed to a linear, high-frequency ultrasonic probe. The probe was pushed cephalad until the stop-light image appeared in order to find the C6 and C5 roots, which are located between the anterior and middle scalene muscles. A 22-gauge echogenic needle was inserted in-plane in a lateral to medial position in the interscalene groove lateral to C5-6 roots.10 Five milliliters of 0.25% bupivacaine were given while the needle stayed still following negative aspiration
Diaphragmatic Excursion
Assessed in centimeters using M-mode ultrasonography (2-5 MHz convex probe) in the supine position as the craniocaudal displacement from baseline to the end of inspiration, and percentage reduction to grade hemidiaphragmatic paresis.
Time frame: Baseline (before block) and at 6, 12, and 24 hours postoperatively
Postoperative Pain Intensity
Assessed using the Numerical Rating Scale (NRS, 0-10)
Time frame: at rest and during shoulder movement at 2, 4, 6, 8, 12, 16, and 24 hours postoperatively
Duration of Analgesia
time from block completion to first rescue analgesia request (NRS ≥ 3)
Time frame: up to 24 hours
Total Opioid Consumption
Intraoperative fentanyl (µg) and postoperative 24-hour IV nalbuphine (mg) consumption.
Time frame: 24 hours
Plan to share: No — Individual participant data will not be shared puplicly due to patient privacy regulations and institutional ethical committee restrictions
No publications or documents are linked to this record.
Ran from Jan 2025 to primary completion in Jan 2026, 12 months.
Of 2,107 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 12 months is close to that.
Counting every sponsor, half of 2,120 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.